AUSTIN, TX / ACCESSWIRE / April 13, 2020 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures announced ...

AUSTIN, TX / ACCESSWIRE / March 8, 2021 / Apollo Endosurgery, Inc. ("Apollo") (NASDAQ:APEN), a global leader in minimally invasive medical devices for gastrointestinal and bariatric procedures, ...

AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for gastrointestinal and bariatric procedures announced today that ...

Loyola Medicine's comprehensive weight loss center is offering a new option to treat obesity - a grapefruit-size gastric balloon that takes up as much as half the volume of the stomach. The Orbera® ...

DAKOTA DUNES, S.D. -- A silicon balloon, which is less invasive than other weight loss procedures, made its debut at Midlands Clinic in 2016. ORBERA, an intragastric balloon, has been used for weight ...

In an example of the continued merging of medical devices and digital health technologies, weight loss device company Apollo Endosurgery and online interaction platform company Zillion have announced ...

AUSTIN, Texas--(BUSINESS WIRE)--Apollo Endosurgery, Inc. (“Apollo”) (Nasdaq:APEN), a global leader in less invasive medical devices for bariatric and gastrointestinal procedures, today announced ...

As most new moms know, post-baby weight can be frustratingly hard to lose. That's why Jennifer, a 24 year old mom from Dallas-Fort Worth, Texas chose to get a little help with an ORBERA™ Intragastric ...

A new, non-invasive and non-surgical weight loss procedure is now available at Midlands Clinic. It is the FDA-approved ORBERA weight loss balloon, a reversible weight loss procedure that Midlands ...

Intragastric balloons are temporary, non-surgical weight-loss devices placed in the stomach to reduce gastric capacity. These devices are used in adults who are overweight or suffer from obesity and ...

Please provide your email address to receive an email when new articles are posted on . The FDA on Monday issued a Letter to Health Care Providers detailing risks for hyperinflation and acute ...